Silke Gillessen and Chris Sweeney discuss how data from the 2020 ESMO and GU ASCO meetings has changed the way they treat prostate cancer.
Silke Gillessen and Chris Sweeney discuss how data from the 2020 ESMO and GU ASCO meetings has changed the way they treat prostate cancer.